D"2R striatopallidal neurons inhibit both locomotor and drug reward processes

Nature Neuroscience

Volumn 12, Issue 4, 2009, Pages 393-395

  Durieux, Pierre F ^a   Bearzatto, Bertrand ^a   Guiducci, Stefania ^b   Buch, Thorsten ^c   Waisman, Ari ^d   Zoli, Michele ^b   Schiffmann, Serge N ^a   De Kerchove D'Exaerde, Alban ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR; ADENOSINE A2 RECEPTOR; DIPHTHERIA TOXIN; DOPAMINE UPTAKE INHIBITOR; ENKEPHALIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; NERVE PROTEIN; SIGNAL PEPTIDE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BRAIN NERVE CELL; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; GENETIC MODEL; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; STRIATE CORTEX; ANIMAL; AUTORADIOGRAPHY; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLOBUS PALLIDUS; INSTRUMENTAL CONDITIONING; METABOLISM; MOUSE; NERVE CELL; PHYSIOLOGY; PROTEIN BINDING; REINFORCEMENT; REWARD; TIME; TRANSGENIC MOUSE;

AMPHETAMINE; ANIMALS; AUTORADIOGRAPHY; CONDITIONING, OPERANT; CORPUS STRIATUM; DIPHTHERIA TOXIN; DOPAMINE UPTAKE INHIBITORS; ENKEPHALINS; GENE EXPRESSION REGULATION; GLOBUS PALLIDUS; GLUTAMATE DECARBOXYLASE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LOCOMOTION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; PROTEIN BINDING; RECEPTORS, ADENOSINE A2; RECEPTORS, DOPAMINE D2; REINFORCEMENT SCHEDULE; REWARD; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 63649090480     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn.2286     Document Type: Article

References (15)

1. Graybiel, A.M. Curr. Biol. 10, 509-511 (2000).
2. Hyman, S.E., Malenka, R.C. & Nestler, E.J. Annu. Rev. Neurosci. 29, 565-598 (2006).
3. Everitt, B.J. & Robbins, T.W. Nat. Neurosci. 8, 1481-1489 (2005).
4. Albin, R.L., Young, A.B. & Penney, J.B. Trends Neurosci. 12, 366-375 (1989).
5. Gerfen, C.R. et al. Science 250, 1429-1432 (1990).
6. Gong, S. et al. Nature 425, 917-925 (2003).
7. Lobo, M.K., Karsten, S.L., Gray, M., Geschwind, D.H. & Yang, X.W. Nat. Neurosci. 9, 443-452 (2006).
8. Shen, W. et al. Nat. Neurosci. 10, 1458-1466 (2007).
9. Kreitzer, A.C. & Malenka, R.C. Nature 445, 643-647 (2007).
10. Bertran-Gonzalez, J. J. Neurosci. 28, 5671-5685 (2008).
11. Buch, T. et al. Nat. Methods 2, 419-426 (2005).
12. Schiffmann, S.N. & Vanderhaeghen, J.J. J. Neurosci. 13, 1080-1087 (1993).
13. Chesselet, M.F. et al. Prog. Brain Res. 99, 143-154 (1993).
14. Sano, H. et al. J. Neurosci. 23, 9078-9088 (2003).
15. Self, D.W. Neuropharmacology 47, 242-255 (2004).